Holdings (Monthly)
Guide ↗
iShares Biotechnology ETF
· iShares Trust| # | Name | Ticker | Since | Shares | Shares Δ | Value | Val Δ% | % Port | Cat |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Alkermes plc | N/A | Mar 2026 | 1,216,662 | NEW | $43.0M | — | 0.53% | EC |
| 2 | Abivax SA | 00370M103 | — | 367,461 | NEW | $40.9M | — | 0.50% | EC |
| 3 | CRISPR Therapeutics AG | N/A | Mar 2026 | 663,733 | NEW | $31.6M | — | 0.39% | EC |
| 4 | Newamsterdam Pharma Co. NV | N/A | Mar 2026 | 537,784 | NEW | $17.2M | — | 0.21% | EC |
| 5 | Kodiak Sciences, Inc. | 50015M109 | — | 422,431 | NEW | $16.1M | — | 0.20% | EC |
| 6 | Caris Life Sciences, Inc. | 142152107 | — | 898,011 | NEW | $16.1M | — | 0.20% | EC |
| 7 | Definium Therapeutics, Inc. | 24477V105 | — | 703,030 | NEW | $13.3M | — | 0.16% | EC |
| 8 | WaVe Life Sciences Ltd. | N/A | Mar 2026 | 1,176,186 | NEW | $8.5M | — | 0.10% | EC |
| 9 | Novocure Ltd. | N/A | Mar 2026 | 763,201 | NEW | $8.3M | — | 0.10% | EC |
| 10 | Biohaven Ltd. | N/A | Mar 2026 | 917,535 | NEW | $7.8M | — | 0.10% | EC |
| 11 | AtaiBeckley, Inc. | 04650F101 | — | 2,160,067 | NEW | $7.6M | — | 0.09% | EC |
| 12 | Sionna Therapeutics, Inc. | 829401108 | — | 185,101 | NEW | $7.4M | — | 0.09% | EC |
| 13 | uniQure NV | N/A | Mar 2026 | 413,699 | NEW | $6.8M | — | 0.08% | EC |
| 14 | MBX Biosciences, Inc. | 55287L101 | — | 199,599 | NEW | $6.0M | — | 0.07% | EC |
| 15 | Maze Therapeutics, Inc. | 578784100 | — | 197,936 | NEW | $5.9M | — | 0.07% | EC |
| 16 | Theravance Biopharma, Inc. | N/A | Mar 2026 | 353,652 | NEW | $5.7M | — | 0.07% | EC |
| 17 | Pharvaris NV | N/A | Mar 2026 | 191,961 | NEW | $5.4M | — | 0.07% | EC |
| 18 | UroGen Pharma Ltd. | N/A | Mar 2026 | 286,041 | NEW | $5.1M | — | 0.06% | EC |
| 19 | Stevanato Group SpA | N/A | Mar 2026 | 370,391 | NEW | $5.1M | — | 0.06% | EC |
| 20 | Septerna, Inc. | 81734D104 | — | 200,845 | NEW | $4.8M | — | 0.06% | EC |
| 21 | Alto Neuroscience, Inc. | 02157Q109 | — | 212,677 | NEW | $4.8M | — | 0.06% | EC |
| 22 | Bicara Therapeutics, Inc. | 055477103 | — | 236,865 | NEW | $4.7M | — | 0.06% | EC |
| 23 | GH Research plc | N/A | Mar 2026 | 334,162 | NEW | $4.7M | — | 0.06% | EC |
| 24 | CytomX Therapeutics, Inc. | 23284F105 | — | 987,397 | NEW | $4.6M | — | 0.06% | EC |
| 25 | MeiraGTx Holdings plc | N/A | Mar 2026 | 430,643 | NEW | $3.7M | — | 0.05% | EC |
| 26 | BioAge Labs, Inc. | 09077V100 | — | 211,362 | NEW | $3.7M | — | 0.05% | EC |
| 27 | Zenas Biopharma, Inc. | 98937L105 | — | 175,941 | NEW | $3.4M | — | 0.04% | EC |
| 28 | Fulcrum Therapeutics, Inc. | 359616109 | — | 429,371 | NEW | $3.3M | — | 0.04% | EC |
| 29 | Prothena Corp. plc | N/A | Mar 2026 | 323,349 | NEW | $3.1M | — | 0.04% | EC |
| 30 | BridgeBio Oncology Therapeutics, Inc. | 107924102 | — | 324,513 | NEW | $2.9M | — | 0.04% | EC |
| 31 | Aclaris Therapeutics, Inc. | 00461U105 | — | 766,012 | NEW | $2.9M | — | 0.04% | EC |
| 32 | Alvotech SA | N/A | Mar 2026 | 763,481 | NEW | $2.6M | — | 0.03% | EC |
| 33 | Contineum Therapeutics, Inc. | 21217B100 | — | 200,362 | NEW | $2.6M | — | 0.03% | EC |
| 34 | Lineage Cell Therapeutics, Inc. | 53566P109 | — | 1,621,430 | NEW | $2.6M | — | 0.03% | EC |
| 35 | ADC Therapeutics SA | N/A | Mar 2026 | 673,142 | NEW | $2.5M | — | 0.03% | EC |
| 36 | Immuneering Corp. | 45254E107 | — | 390,008 | NEW | $2.1M | — | 0.03% | EC |
| 37 | Upstream Bio, Inc. | 91678A107 | — | 213,032 | NEW | $1.9M | — | 0.02% | EC |
| 38 | Cabaletta Bio, Inc. | 12674W109 | — | 633,353 | NEW | $1.7M | — | 0.02% | EC |
| 39 | Candel Therapeutics, Inc. | 137404109 | — | 294,995 | NEW | $1.4M | — | 0.02% | EC |
| 40 | OmniAb, Inc. | 68218J103 | — | 874,147 | NEW | $1.4M | — | 0.02% | EC |
| 41 | NovaBridge Biosciences | 44975P103 | — | 539,518 | NEW | $1.3M | — | 0.02% | EC |
| 42 | AC Immune SA | N/A | Mar 2026 | 443,438 | NEW | $1.2M | — | 0.02% | EC |
| 43 | Caribou Biosciences, Inc. | 142038108 | — | 594,484 | NEW | $1.1M | — | 0.01% | EC |
| 44 | Cellectis SA | 15117K103 | — | 339,873 | NEW | $1.1M | — | 0.01% | EC |
| 45 | Sagimet Biosciences, Inc. | 786700104 | — | 189,187 | NEW | $989K | — | 0.01% | EC |
| 46 | Quantum-Si, Inc. | 74765K105 | — | 1,223,534 | NEW | $947K | — | 0.01% | EC |
| 47 | Tenaya Therapeutics, Inc. | 87990A106 | — | 1,200,002 | NEW | $831K | — | 0.01% | EC |
| 48 | Black Diamond Therapeutics, Inc. | 09203E105 | — | 321,542 | NEW | $685K | — | 0.01% | EC |
| 49 | Gossamer Bio, Inc. | 38341P102 | — | 1,510,536 | NEW | $496K | — | 0.01% | EC |
| 50 | Jyong Biotech Ltd. | N/A | Mar 2026 | 206,499 | NEW | $444K | — | 0.01% | EC |
| 51 | Akero Therapeutics, Inc. | 009CVR044 | — | 515,954 | NEW | $341K | — | 0.00% | — |
| 52 | Aardvark Therapeutics, Inc. | 002942100 | — | 89,682 | NEW | $338K | — | 0.00% | EC |
| 53 | N/A | N/A | Mar 2026 | 33 | NEW | $56K | — | 0.00% | DE |
| 54 | N/A | N/A | Mar 2026 | 53 | NEW | $-73747 | — | -0.00% | DE |